Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 131 Colonic Neoplasms 72 Rectal Neoplasms 61 Breast Neoplasms 61 Stomach Neoplasms 37 Pancreatic Neoplasms 31 Squamous Cell Carcinoma of Head and Neck 27 Esophageal Neoplasms 24 Head and Neck Neoplasms 23 Neoplasm Metastasis 22 Esophageal Squamous Cell Carcinoma 16 Carcinoma, Hepatocellular 16 Adenocarcinoma Of Esophagus 16 Parkinson Disease 4, Autosomal Dominant Lewy Body 14 Neoplasms 11 Nasopharyngeal Carcinoma 11 Adenocarcinoma 7 Urinary Bladder Neoplasms 5 Keratosis, Actinic 5 Cholangiocarcinoma 5 Anus Neoplasms 5 Intestinal Neoplasms 4 Inflammatory Breast Neoplasms 4 Hepatoblastoma 4 Gastrointestinal Neoplasms 4 Digestive System Neoplasms 4 Biliary Tract Neoplasms 4 Laryngeal Neoplasms 3 Hypopharyngeal Neoplasms 3 HIV Infections 3

Interventions

tyramine-deoxysorbitol 1 Triamcinolone Acetonide 1 Triamcinolone 1 Fluorouracil 1 Curettage 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Chalazion × Fluorouracil × Clear all

NCT02025023 2020-02-06

CTS

University of Washington

Phase 3 Recruiting

Pain, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡